MedPath

Preventive intervention of mild cognitive impairment in Anhui, China

Not Applicable
Conditions
Mild cognitive impairment (MCI)
Mental and Behavioural Disorders
Mild cognitive disorder
Registration Number
ISRCTN15775827
Lead Sponsor
ational Natural Science Foundation of China
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Aged 55-75 years, male or female
2. Owning a smartphone, have Instant Messenger (e.g., WeChat), and can use it proficiently
3. Is a permanent resident of the community and has no plan to leave the community for a long-term residence elsewhere within 1 year
4. Normal cognitive function (MMSE score of 24 or higher)
5. Be aware of the purpose of this study and willing to participate (sign informed consent)

Exclusion Criteria

Older adults with MCI or AD at baseline

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change in the total risk score of each individual was used as the main observation index at baseline and at 8, 16, and 24 weeks
Secondary Outcome Measures
NameTimeMethod
<br> 1. Somatic function measured using the results evaluated by neurology professionals at baseline and at 8, 16, and 24 weeks<br> 2. Cognitive function measured using the Mini-Mental State Examination (MMSE) at baseline and at 8, 16, and 24 weeks<br> 3. Activities of daily living measured using the activities of daily living (ADL) at baseline and at 8, 16, and 24 weeks<br> 4. Psychological status measured using the 9-item Patient Health Questionnaire (PHQ-9) at baseline and at 8, 16, and 24 weeks<br> 5. Quality of life measured using the EQ-5D at baseline and at 8, 16, and 24 weeks<br>
© Copyright 2025. All Rights Reserved by MedPath